140 |
Gwangju FC and Kuala Lumpur City FC sign mutual business agreement
HOT
2025-03-31
330
(주)아디포랩스
|
(주)아디포랩스 |
2025-03-31 |
330 |
139 |
Gwangju FC and Kuala Lumpur City FC sign mutual business agreement
HOT
2025-03-31
302
(주)아디포랩스
|
(주)아디포랩스 |
2025-03-31 |
302 |
138 |
Gwangju FC and Kuala Lumpur City FC sign mutual business agreement
HOT
2025-03-31
293
(주)아디포랩스
|
(주)아디포랩스 |
2025-03-31 |
293 |
136 |
AdipoLABs Announces REMISSION 1℃ Clinical Results at 6th IVRA
HOT
2025-03-31
316
(주)아디포랩스
|
(주)아디포랩스 |
2025-03-31 |
316 |
135 |
“This is how I overcame cancer” IVRA International Cancer Treatment Seminar launches
HOT
2024-07-30
982
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-30 |
982 |
133 |
AdipoLABs takes the lead in physical strength improvement and health care for Gwangju FC soccer players
HOT
2024-07-30
1085
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-30 |
1085 |
132 |
AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China
HOT
2024-07-30
968
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-30 |
968 |
131 |
Cooperation between Korea and China to promote cancer patient treatment begins in earnest
HOT
2024-07-30
941
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-30 |
941 |
129 |
High-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ enters Mongolia in a matter of time
HOT
2024-07-26
915
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-26 |
915 |
128 |
AdipoLABs, Grand Prize at ‘K-First in Class’ for 8 consecutive years
HOT
2024-07-26
929
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-26 |
929 |
127 |
AdipoLABs enters the market with high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’
HOT
2024-07-11
973
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-11 |
973 |
126 |
“We will work harder for the development of the country and the company.”
HOT
2024-07-11
976
(주)아디포랩스
|
(주)아디포랩스 |
2024-07-11 |
976 |